Inventiva S.A. current report, Q4 FY2023

Inventiva S.A. Form 6-K Summary

Business Context and Reporting Period

Inventiva S.A., a French foreign private issuer headquartered in Daix, France, filed this Form 6-K for November 2023. The filing reports that the company issued a press release dated November 21, 2023, which is incorporated by reference as Exhibit 99.1.

Financial Metrics

The filing text provided does not include the contents of the referenced press release and therefore does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, cash balance, or other financial metrics.

Changes Versus Prior Period

The filing text does not provide information sufficient to identify material changes versus a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not include management guidance, outlook, risk disclosures, contingencies, or unusual items. These matters may be addressed in Exhibit 99.1, but the exhibit’s contents were not provided.

Important Investor Verification Items

  • Obtain and review Exhibit 99.1, the press release dated November 21, 2023.
  • Verify any reported clinical, regulatory, operational, or financing developments described in the press release.
  • Confirm the company’s cash runway, liquidity position, financing needs, and any related going-concern or dilution considerations.
  • Review the company’s latest Form 20-F and subsequent filings for complete financial results and material risk factors.